PR Newswire SAN FRANCISCO and SUZHOU, China, May 6, 2025 SAN FRANCISCO and SUZHOU, China, May 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ...
PR Newswire NEW YORK, April 23, 2025 The Breakthrough T1D U-M-OHSU Cardiorenal Center of Excellence to focus on heart and kidney disease in type 1 diabetes NEW YORK, April 23, 2025 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the ...
PR Newswire KYOTO, Japan, April 22, 2025 KYOTO, Japan, April 22, 2025 /PRNewswire/ -- A new study has found that 10-hydroxy-cis-12-octadecenoic acid (HYA), a metabolite derived from linoleic acid by gut microbiota, can help reduce ...
PR Newswire STOCKHOLM, April 21, 2025 STOCKHOLM, April 21, 2025 /PRNewswire/ -- In a recent investor interview, Diamyd Medical Board Member Professor Mark Atkinson and CEO Ulf Hannelius shared key insights into the Company's positioning as a ...
PR Newswire BRONX, N.Y., April 8, 2025 BRONX, N.Y., April 8, 2025 /PRNewswire/ -- Malnutrition-related diabetes—typically affecting lean, malnourished teens and young adults in low- and middle-income countries—is now officially recognized as ...
PR Newswire BRUSSELS, April 7, 2025 New estimates from the IDF Diabetes Atlas highlight the growing diabetes threat, with nearly one in nine adults now living with the condition. BRUSSELS, April 7, 2025 /PRNewswire/ -- Globally, nearly ...
PR Newswire SINGAPORE, March 26, 2025 'Sponge-like' microneedle patches deliver bioactive ingredients and reduce inflammation in slow- and non-healing wounds SINGAPORE, March 26, 2025 /PRNewswire/ -- Diabetic wounds often lead to severe ...
PR Newswire FAYETTEVILLE, Ark and BETHEL, Conn., March 18, 2025 FAYETTEVILLE, Ark and BETHEL, Conn., March 18, 2025 /PRNewswire/ -- SFC Fluidics, Inc. ("SFC") and Duracell U.S. Operations, Inc. ("Duracell") are collaborating to efficiently ...
PR Newswire PALO ALTO, Calif., March 10, 2025 PALO ALTO, Calif., March 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer ...
PR Newswire AUSTIN, Texas, Feb. 28, 2025 AUSTIN, Texas, Feb. 28, 2025 /PRNewswire/ -- The American Association of Nurse Practitioners® (AANP) applauds the introduction of The Promoting Access to Diabetic Shoes Act by Representatives Darin ...
Metformin shows promise in reducing knee osteoarthritis pain in overweight individuals and delaying surgery.
Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are managed.
Persistent social isolation impacts the nutritional habits of older Canadian women, contributing to poorer overall diet quality and health outcomes as they age.
Smartwatches and wearable health technology empower Type 2 Diabetes (T2D) patients to stay active, track progress, and maintain healthy blood sugar levels.
Study reveals how diabetes rewires the brain, affecting memory and reward processing by linking high blood sugar to changes in the anterior cingulate cortex.
Subscribe to our Free Newsletters!